GURUFOCUS.COM » STOCK LIST » Technology » Software » Imperva Inc (NAS:IMPV) » Definitions » EBITDA

Imperva (Imperva) EBITDA : $3.1 Mil (TTM As of Sep. 2018)


View and export this data going back to 2011. Start your Free Trial

What is Imperva EBITDA?

Imperva's EBITDA for the three months ended in Sep. 2018 was $3.6 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Sep. 2018 was $3.1 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Imperva's EBITDA per Share for the three months ended in Sep. 2018 was $0.10. Its EBITDA per share for the trailing twelve months (TTM) ended in Sep. 2018 was $0.09.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Imperva EBITDA Historical Data

The historical data trend for Imperva's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imperva EBITDA Chart

Imperva Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBITDA
Get a 7-Day Free Trial Premium Member Only -22.79 -52.93 -41.84 -52.02 -1.45

Imperva Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.76 6.04 -5.44 -1.16 3.62

Competitive Comparison of Imperva's EBITDA

For the Software - Application subindustry, Imperva's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imperva's EV-to-EBITDA Distribution in the Software Industry

For the Software industry and Technology sector, Imperva's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Imperva's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Imperva's EBITDA for the fiscal year that ended in Dec. 2017 is calculated as

Imperva's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2017, Imperva's EBITDA was $-1.4 Mil.

Imperva's EBITDA for the quarter that ended in Sep. 2018 is calculated as

Imperva's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Sep. 2018, Imperva's EBITDA was $3.6 Mil.

EBITDA for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Imperva  (NAS:IMPV) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Imperva EBITDA Related Terms

Thank you for viewing the detailed overview of Imperva's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Imperva (Imperva) Business Description

Traded in Other Exchanges
N/A
Address
Imperva provides application and data cybersecurity products for enterprises and governments. The company was founded in 2002 and went public in 2011. Imperva reports in two operating segments (products and services) across three geographies (Americas; Europe, Middle East, and Africa; and Asia-Pacific).
Executives
James R Tolonen director
Randall N Spratt director C/O MCKESSON CORPORATION, ONE POST STREET, 33RD FLOOR, SAN FRANCISCO CA 94104
Allan R Tessler director C/O EPOCH HOLDING CORPORATION, 640 FIFTH AVENUE, NEW YORK, NY 10019
Albert A Pimentel director CO GLU MOBILE INC, 1800 GATEWAY DRIVE, SAN MATEO CA 94404
Tram T Phi officer: Chief Legal Officer C/O DOCUSIGN, INC., 221 MAIN STREET, SUITE 1550, SAN FRANCISCO CA 94105
Christopher Hylen director, officer: President and CEO 700 LOCUST STREET, 4TH FLOOR, DUBUQUE IA 52001
Geraldine Elliott director 1194 N. MATHILDA AVE., SUNNYVALE CA 94089
Anthony J Bettencourt director C/O IMPERVA, INC. 3400 BRIDGE PARKWAY REDWOOD SHORES CA 94065
Charles H Giancarlo director 170 WEST TASMAN DRIVE, SAN JOSE X1 95134
Shlomo Kramer 10 percent owner
Ranzetta Theresia Gouw director 428 UNIVERSITY AVE, PALO ALTO CA 94301
Frank Slootman director 106 EAST BABCOCK STREET, SUITE 3A, BOZEMAN MT 59715
Gregory S. Clark director EMULEX CORPORATION, 3333 SUSAN STREET, COSTA MESA CA 92626
Steven M Krausz director 2735 SAND HILL ROAD, MENLO PARK CA 94025
David N Strohm director EMC CORPORATION, 176 SOUTH STREET, HOPKINTON MA 01748